By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Genelex Corporation 

3000 First Ave., Suite One

Seattle  Washington  98121  U.S.A.
Phone: 206-382-9591 or 800-523-3080 Fax: 206-219-4000




Company News
Genelex Corporation Rolls Out Lifesaving DNA Healthcare System 9/13/2012 9:56:41 AM
Genelex Corporation Receives First Patent on Business Methods for Pharmacogenetics 8/1/2012 10:25:52 AM
Genelex Corporation Release: Coumadin (warfarin) Patients Receive New FDA Information 8/17/2007 11:15:53 AM
Genelex Corporation Release: Controversial FDA Panel Approves Drug For Use By Children; New DNA Test Alerts Physicians And Parents To Potential Harm 12/7/2006 11:58:00 AM
Genelex Corporation Release: FDA Committee Supports Simple DNA Tests When Patients Are Prescribed Coumadin (Warfarin) 11/21/2006 10:14:34 AM
Genelex Corporation Release: DNA Tests Now Available Determine Safe Dosage For Dangerous Drugs, Coumadin And Warfarin 10/4/2006 10:20:20 AM
Strattera Safety Helped By DNA Testing, According To FDA Approved Product Labeling Notes Genelex Corporation Founder, Howard Coleman10/19/2005 5:12:58 PM
DNA-Based Personalized Medicine Training Announced By Genelex Corporation10/19/2005 5:12:58 PM
DNA Tests Now Available Reveal Possible Deadly Side Effects; Genelex Corporation Urges Users Of Vioxx, Bextra, Celebrex, Aleve And Others To Check DNA Before Taking Meds10/19/2005 5:11:51 PM
Genelex Corporation Release: Gene Tests Available To Consumers10/19/2005 5:09:33 PM